Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125662941 | 12566294 | 1 | I | 201408 | 20160705 | 20160718 | 20160718 | EXP | CA-HQ SPECIALTY-CA-2016INT000547 | INTERCHEM | 0.00 | Y | 0.00000 | 20160718 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125662941 | 12566294 | 1 | PS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | UNK | N | 201749 | ||||||||||
| 125662941 | 12566294 | 2 | SS | METHOTREXATE SODIUM. | METHOTREXATE SODIUM | 1 | 2.1429 MG (15 MG,1 IN 1 W) | N | 201749 | 15 | MG | ||||||||
| 125662941 | 12566294 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | UNK | N | 0 | ||||||||||
| 125662941 | 12566294 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | UNK | N | 0 | ||||||||||
| 125662941 | 12566294 | 5 | SS | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 10 MG, UNK | 0 | 10 | MG | |||||||||
| 125662941 | 12566294 | 6 | SS | PLAQUENIL /00072602/ | HYDROXYCHLOROQUINE DIPHOSPHATE | 1 | 400 MG,1 IN 1 D | N | 0 | 400 | MG | ||||||||
| 125662941 | 12566294 | 7 | C | HUMIRA | ADALIMUMAB | 1 | UNK | 0 | |||||||||||
| 125662941 | 12566294 | 8 | C | PREDNISONE. | PREDNISONE | 1 | UNK, TAPERING | 0 | |||||||||||
| 125662941 | 12566294 | 9 | C | CYMBALTA | DULOXETINE HYDROCHLORIDE | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125662941 | 12566294 | 1 | Rheumatoid arthritis |
| 125662941 | 12566294 | 3 | Rheumatoid arthritis |
| 125662941 | 12566294 | 5 | Product used for unknown indication |
| 125662941 | 12566294 | 6 | Product used for unknown indication |
| 125662941 | 12566294 | 7 | Product used for unknown indication |
| 125662941 | 12566294 | 8 | Product used for unknown indication |
| 125662941 | 12566294 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125662941 | 12566294 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125662941 | 12566294 | Alopecia | |
| 125662941 | 12566294 | Back pain | |
| 125662941 | 12566294 | Cough | |
| 125662941 | 12566294 | Gait disturbance | |
| 125662941 | 12566294 | Oedema | |
| 125662941 | 12566294 | Paraesthesia | |
| 125662941 | 12566294 | Post procedural infection | |
| 125662941 | 12566294 | Productive cough | |
| 125662941 | 12566294 | Swelling face | |
| 125662941 | 12566294 | Synovitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125662941 | 12566294 | 1 | 2001 | 0 | ||
| 125662941 | 12566294 | 2 | 200703 | 20160623 | 0 | |
| 125662941 | 12566294 | 3 | 2012 | 2015 | 0 | |
| 125662941 | 12566294 | 4 | 20150922 | 0 | ||
| 125662941 | 12566294 | 5 | 200703 | 0 | ||
| 125662941 | 12566294 | 6 | 200612 | 201003 | 0 | |
| 125662941 | 12566294 | 7 | 200803 | 200901 | 0 | |
| 125662941 | 12566294 | 8 | 20150922 | 0 |